Trend of Congenital Hypothyroidism Incidence and Its Affecting Factors in Shahr-e-Kord, Western Iran
Background: Congenital hypothyroidism is one of the most common endocrine disrupters and metabolism, and is one of the most important preventable causes of physical and mental disabilities.
Results: Overall, 111 cases were diagnosed with hypothyroidism, which made the prevalence value equal to 2 cases per 1000 births. The prevalence in females and males was 1.9 and 2.2 per 1,000 birth, respectively. The odds ratio for this disorder was 4.47(2.42-9.28) for the neonates with a family history of hypothyroidism and 1.72(1.05-2.82) for those born through cesarean.
Conclusion: The incidence of this disorder is similar in males and females, and the incidence of this disease in people with a family history is far more than others.
2. Taheri-Soodejani M, Fallahzadeh H, Lotfi MH et al (2017). Screening for congenital hypothyroidism in Shahr-e-Kord: prevalence and recall rate during 2006-2014. FEYZ, 20(6): 574-80
3. Bernal J, Guadaño-Ferraz A, Morte B (2015). Thyroid hormone transporters—functions and clinical implications. Nat Rev Endocrinol, 11(7): 406-17.
4. LaFranchi SH (2011). Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab, 96(10): 2959-67.
5. Zeinalzadeh AH, Talebi M (2012). Neonatal screening for congenital hypothyroidism in East Azerbaijan, Iran: the first report. J Med Screen, 19(3): 123-6.
6. Goodarzi E, Ghaderi E, Khazaei S, Alikhani A et al (2017). The prevalence of transient and permanent congenital hypothyroidism in infants of Kurdistan Province, Iran (2006-2014). Int J Pediatr, 5(2): 4309-18.
7. Hashemipour M, Hovsepian S, Kelishadi R et al (2009). Permanent and transient congenital hypothyroidism in Isfahan–Iran. J Med Screen, 16(1): 11-6.
8. Ford G, LaFranchi SH (2014). Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab, 28(2): 175-87.
9. Fan X, Chen S, Qian J et al (2015). Incidence and interrelated factors in patients With congenital hypothyroidism as detected by newborn screening in Guangxi, China. Glob Pediatr Health, 2: 1-5.
10. Rastogi MV, LaFranchi SH (2010). Congenital hypothyroidism. Orphanet J Rare Dis, 5(1): 17.
11. Polak M, Legac I, Vuillard E et al (2006). Congenital hyperthyroidism: the fetus as a patient. Horm Res Paediatr, 65(5): 235-42.
12. Harris KB, Pass KA (2007). Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab, 91(3): 268-77.
13. Yarahmadi S, Ali Mohammadzadeh K, Tabibi S, Maleki M, editors (2011). Presenting mathematics model of cost-benefit calculation of screening for congenital hypothyroidism in Iran. Int Math Forum, 6(14): 681-97.
14. Dalili S, Rezvany SM, Medghalchi A et al (2012). Congenital hypothyroidism: a review of the risk factors. Acta Med Iran, 50(11):735-9.
15. Namakin K, Sedighi E, Sharifzadeh G, Zardast M (2012). Prevalence of congenital hypothyroidism In South Khorasan province (2006-2010). JBUS, 19(2): 191-9.
16. Haghshenas M, Pasha YZ, Ahmadpour-Kacho M, Ghazanfari S (2012). Prevalence of permanent and transient congenital hypothy-roidism in Babol City-Iran. Med Glas, 9(2): 341-4.
17. Safari F, Karimzadeh T, Mostafavi F, Mahram M (2009). Screening of congenital hypothyroidism in Qazvin province (2006-2008). JQUMS, 12(4): 43-49.
18. Hashemipour M, Dehkordi EH, Hovsepian S, Amini M, Hosseiny L (2010). Outcome of congenitally hypothyroid screening program in Isfahan: Iran from prevention to treatment.
Int J Prev Med, 1(2): 92–97.
19. Majid V, Saeideh M, Ali N, Zahra S (2011). High incidence and recall rate of congenital hypothyroidism in Zanjan province, a health problem or a study challenge? Int J Endocrinol Metab, 4(3): 338-342.
20. Noori Shadkam M, Jafarizadeh M, Mirzaei M et al (2008). Prevalence of Congenital Hypothyroidism and Transient Increased Levels of TSH in Yazd Province. JSSU, 16(3): 315.
21. Zhao D-H, Shen Y, Gong J-M, Meng Y, Su L, Zhang X (2016). Newborn screening for congenital hypothyroidism in Henan province, China. Clin Chim Acta, 452: 58-60.
22. Abdelmoktader AM (2013) . Risk factors for congenital hypothyroidism in Egypt: results of a population case-control study (2003-2010). Ann Saudi Med,33(3): 273.
23. Anjum A, Afzal MF, Iqbal SMJ, Sultan MA, Hanif A (2014). Congenital hypothyroidism in neonates. IJEM, 18(2): 213–216.
24. Medda E, Olivieri A, Stazi MA et al (2005). Risk factors for congenital hypothyroidism: results of a population case-control study (1997–2003). Eur J Endocrinol, 153(6): 765-73.
25. Bijarnia S, Wilcken B, Wiley VC (2011). Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. J Inherit Metab Dis, 34(3): 827-33.
26. Simsek E, Karabay M, Kocabay K (2005). Neonatal screening for congenital hypothyroidism in West Black Sea area, Turkey. Int J Clin Pract, 59(3): 336-41.
27. Carvalho DDT, Rocha DRTW, Arbex AK (2016). Hypothyroidism in Childhood and Adolescence. Open J Endocr Metab Dis, 6(01): 72.
28. Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR (2008). Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid, 18(1): 67-76.
29. McElduff A, McElduff P, Wiley V, Wilcken B (2005). Neonatal thyrotropin as measured in a congenital hypothyroidism screening program: influence of the mode of delivery. J Clin Endocrinol Metab, 90(12): 6361-3.